ESR1 and breast cancer: In a previous study (Wu et al., 2016), we screened potential ligands for a nuclear receptor named ERα, which served as a potential target for ERα-positive breast cancer (Nilsson et al., 2011), from the Enamine database1 via a strategy combining 2D chemical similarity searching and the bSDTNBI method.